Table 18. Rationality behind the used formulation in COVID-19 during 14 days-28 days (Jirna Jwara phase) in Standard of care Group (Group 2) – Allopathic Medicine Track.

*n represents the count of patients who received the specified medication within the given timeframe

+Dosage and frequency were decided based on the Allopathic physician’s clinical judgement

Medicine Name	Rationale	Dosage+	n (%)*	Frequency of intake+
Metformin	Anti-diabetic drugs	500mg	7 (77.7%)	Once-Twice
Apixaban	Antihypertensive drugs	2.5mg	2 (22.2%)	Twice
Paracetamol	Helps relieve pain and fever by blocking the release of certain chemical messengers responsible for fever and pain.	650mg	2 (22.2%)	SOS
Aspirin	An antiplatelet medicine used to treat and prevent heart attacks, strokes, and heart-related chest pain (angina).	75mg	2 (22.2%)	Once
Glimepiride	Anti-diabetic drugs	1-2mg/dose	2 (22.2%)	Once-Twice